相关实验视频
Updated: Jun 2, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
妊娠期BMI超过23kg/m2可能会增加妊娠期糖尿病患者的胰岛素使用量
Risa Nakamura1, Tsuyoshi Ohkura1, Sonoko Kitao1
1Department of Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, JPN.
对于患有妊娠糖尿病 (GDM) 的日本妇女来说,孕期BMI超过23公斤/平方米会增加需要胰岛素治疗的可能性. 产后葡萄糖耐受性是相似的,无论GDM治疗类型.
科学领域:
- 内分泌学 在内分泌学.
- 产科 产科 产科 产科 产科
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 孕期糖尿病 (GDM) 影响母亲和胎儿的健康.
- 孕期BMI是已知的GDM并发症的风险因素.
- 针对GDM的最佳管理策略对于产后健康至关重要.
研究的目的:
- 为了确定与日本GDM患者胰岛素使用相关的孕期BMI值.
- 评估GDM治疗类型对产后葡萄糖耐受性的影响.
主要方法:
- 对21名日本GDM患者 (2013-2017年) 的回顾性分析.
- 接收器操作特征 (ROC) 曲线分析以确定胰岛素治疗的BMI截止值.
- 在饮食和胰岛素治疗组之间比较产后葡萄糖耐受性标志物.
主要成果:
- 妊娠前BMI为22.5kg/m2被确定为胰岛素治疗的显著切断点 (灵敏度为100%).
- 胰岛素使用量在BMI≥22.5kg/m2 (p=0.045) 的患者中显著增加 (p=0.045).
- 产后葡萄糖耐受性,HOMA-IR,HOMA-β和IGI根据GDM治疗 (饮食与胰岛素) 不存在差异.
结论:
- 患有GDM和妊娠期BMI>23 kg/m2的日本女性面临需要胰岛素治疗的风险增加.
- GDM治疗方式 (饮食与胰岛素) 似乎没有影响产后葡萄糖耐受性.
更多相关视频
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...